JG

J.G.Chemicals

₹570.5 -16.90 (-2.88%) EOD · 16 Nov 2026
DCF model value ₹453−20.6%
Market price ₹570.5 -16.90 (-2.88%)EOD · 16 Nov 2026
DCF model value

The model puts J.G.Chemicals at ₹453 per share — 20.6% below today's price.

Model estimate · 4 yrs of reported financials · dated 16 Nov 2026

All values are mathematically derived from financial models and do not constitute buy, sell, or hold recommendations. Models rely on historical data and assumptions that may not reflect future outcomes. StockRank is not a registered investment advisor — always do your own research before making investment decisions.

DCF model history

JGCHEM is close to its usual level against the model.It was this expensive or more on 49% of days in the past 5 years.

JGCHEM is in its usual valuation range

Cheaper than on 49% of days over 5 years

Cheap Usual Expensive
Today · 26% above model

After days like today

Cheap days +12% typical return within 1 d – 2 mo 14 periods in 5 years
Expensive days −16% typical return within 1 d – 7 mo 8 periods in 5 years

Past results do not predict future returns.

360° view

Five pillar scores with 360° stock score 71Value: 44 out of 100. Quality: 63 out of 100. Growth: 74 out of 100. Health: 96 out of 100. Momentum: 78 out of 100. Longer petals indicate higher scores.71 How much you pay for what the business earns and owns, compared with similar companies. How well the business uses its money to earn steady profits and bring in cash. How quickly the business is growing its sales and profits over time. How comfortably the business can pay its bills and manage its debts. Recent share-price moves and changes in earnings and institutional ownership.
✦ AI ANALYSIS

The takeaway

A zinc-chemicals maker with strong reported growth, a nearly debt-free balance sheet and solid returns, offset by thin margins and a market-implied scenario value below the current share price.

↗ Strengths

  • Reported growth has been strong: five-year net profit and revenue growth are elevated, and recent quarterly revenue and profit rose sharply year on year.
  • The balance sheet shows very low borrowings relative to equity, high interest coverage and cash exceeding debt, alongside a 71% promoter holding with no pledging.
  • Return on capital has been solid, with a five-year median ROCE near 19% and positive profit in each of the last ten years.

↘ Risks to watch

  • Profitability is thin: operating and net margins are modest, and operating cash flow covers only about two-thirds of net profit.
  • The three-year price-return input is unavailable, and the model flags that net reinvestment exceeded operating profit in some projected years without a financing plan.

J.G. Chemicals manufactures and sells zinc oxide and zinc sulphate, marketed under the Luxmi brand, serving industries such as rubber, ceramics, paints, pharmaceuticals, cosmetics, electronics, agrochemicals and animal feed. It operates in India and internationally, with reported revenue labels spanning zinc oxide, exports benefits and raw materials, and sales split between India and foreign countries. Available business descriptions differ on headquarters location, one citing Kolkata and another Salt Lake, India.

Key metrics

Latest reported · price-based figures use the EOD quote
Share price multiplied by the number of shares, shown in crore rupees. It measures the market value of equity, not the value of the entire business including debt. 2,301.79 Cr
Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive. 26.31
Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read. 4.36
Enterprise value relative to trailing 12-month earnings before interest, tax, depreciation and amortisation. It includes debt in valuation but does not account for capital spending or all cash needs. 19.70
Annual dividends per share as a percentage of the share price. Dividends can change, and a falling price can raise the yield. 0.19%
Operating profit relative to the capital used in the business. It indicates capital efficiency, but industry capital needs and accounting values affect comparisons. 17.04%
Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business. 12.46%
Borrowings relative to shareholder equity. More borrowing can increase financing risk; the ratio has different meaning for lenders and is not useful with nonpositive equity. 0.01
The relative strength index compares recent price gains and losses over 14 periods on a 0–100 scale. Extreme readings can persist and do not reliably time a reversal. 48.2
A count of nine accounting checks covering profitability, financial position and operating efficiency. More checks passed does not guarantee future performance, and the measure is less suited to financial businesses. 6 / 9

5 scoring axes

How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.

44/100

How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.

Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read.
4.36×
Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive.
26.31×
P/E divided by the earnings-growth rate used in the ratio. Its meaning depends on that growth period and whether growth is sustainable.
0.66×
Enterprise value relative to trailing 12-month earnings before interest, tax, depreciation and amortisation. It includes debt in valuation but does not account for capital spending or all cash needs.
19.70×
Reported annual operating cash flow as a percentage of current market value of equity. This is before capital spending, so it is not free cash flow.
1.89%
Percentage difference between the saved valuation estimate and its reference share price. It depends on assumptions and is not a forecast return.
-22.86%

Profitability, capital efficiency, and consistency of cash generation.

63/100

Profitability, capital efficiency, and consistency of cash generation.

Net profit as a percentage of revenue over the trailing 12 months. Tax, financing and one-off items can affect the margin.
7.22%
Operating profit as a percentage of revenue over the trailing 12 months. It reflects operating profitability before financing and tax, and varies by industry.
9.56%
A count of nine accounting checks covering profitability, financial position and operating efficiency. More checks passed does not guarantee future performance, and the measure is less suited to financial businesses.
6 / 9
Operating profit relative to the capital used in the business. It indicates capital efficiency, but industry capital needs and accounting values affect comparisons.
17.04%
Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business.
12.46%
Operating cash flow divided by common net profit for the same annual period. It shows how earnings translate into operating cash, but working-capital timing can move the ratio.
0.66×
The share of observed annual periods with positive common earnings within the last ten years. It describes profit frequency, not the size or stability of those profits.
100.00%
The middle annual return on capital employed from the five-year history. It reduces the influence of a single unusual year but can hide recent changes.
19.07%

Revenue and earnings growth rates across multiple time horizons.

74/100

Revenue and earnings growth rates across multiple time horizons.

Operating cash flow growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
11.82%
Earnings-per-share growth expressed as a compounded annual rate over three years. Changes in share count and one-off profits can affect the rate.
6.24%
Net profit growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
6.24%
Net profit growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
22.96%
Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
63.89%
Revenue growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
7.44%
Revenue growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
17.45%

Balance sheet strength, leverage, and financial stability.

96/100

Balance sheet strength, leverage, and financial stability.

Cash and cash equivalents divided by borrowings. It shows how much borrowing is covered by reported cash, which may not all be freely available.
5.96×
Current assets divided by current liabilities. It describes short-term balance-sheet coverage, but inventories and receivables may not turn into cash quickly.
18.64×
Borrowings relative to shareholder equity. More borrowing can increase financing risk; the ratio has different meaning for lenders and is not useful with nonpositive equity.
0.01×
Earnings available to cover interest expense, expressed as a multiple. It indicates interest-payment capacity but does not cover principal repayments or all cash needs.
181.55×
The share of promoter holdings pledged as collateral. Pledging can create financing pressure if collateral values fall; zero pledging does not remove other risks.
0.00%
The percentage of shares held by promoters. Ownership concentration can align interests but does not by itself establish governance quality.
71.00%

Recent price moves and changes in earnings and institutional ownership.

78/100

Recent price moves and changes in earnings and institutional ownership.

Change in the share of equity held by domestic institutional investors over one year, in percentage points. It describes ownership changes, not the cash they invested or future returns.
-1.10 pp
The latest quarterly operating margin minus the average of the preceding four quarters, in percentage points. It describes a margin change, not percentage growth in profit.
1.69 pp
Net profit change from the same quarter a year earlier. One-off items and a small comparison-period profit can make the percentage unusually large.
85.49%
Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
63.89%
Share-price change over one year. Past price performance does not predict future returns.
42.21%
Share-price change over three years in total, not per year. Past price performance does not predict future returns.
—

Peer Companies

Commodity Chemicals
Financial Statements

Quarterly Results

₹ Cr · per share in ₹
RevenueNet profit ₹ crore
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
− Revenue
Revenue209.08224.25218.01220.28248.47286.17315.65361.01
Revenue Growth YoY29.61%23.65%7.64%3.87%18.84%27.61%44.78%63.89%
− Profitability
Operating Profit23.1019.4819.8017.9622.7721.4833.5238.07
OPM %11.05%8.69%9.08%8.15%9.16%7.51%10.62%10.55%
Profit Before Tax23.9621.5521.8420.3524.5125.4134.9737.24
− Bottom Line
Net Profit16.9715.3415.7714.3917.5018.2125.0826.70
Net Profit Growth YoY66.07%17.27%3.80%-12.81%3.14%18.68%59.03%85.49%
EPS4.333.924.033.674.504.616.406.81
Financial Statements

Income Statement

Annual · ₹ Cr · per share in ₹
RevenueNet profit ₹ crore
ParticularsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Revenue
Revenue435.30612.83784.58667.69847.94972.93
Revenue Growth—40.78%28.03%-14.90%27.00%14.74%
− Expenses & Profitability
Operating Profit43.5056.1675.5045.3186.1282.02
OPM %9.88%9.01%9.51%6.71%10.04%8.29%
Profit Before Tax41.2057.4576.6943.1089.9092.11
− Bottom Line
Net Profit23.4440.0054.9430.8664.0265.88
Profit Growth—70.65%37.35%-43.83%107.45%2.91%
EPS7.3912.6117.329.6016.3416.81
Financial Statements

Balance Sheet

Annual · ₹ Cr
Total assetsTotal liabilities ₹ crore

Liabilities shown exclude shareholders’ funds and other equity. Assets equal liabilities plus equity.

ParticularsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Equity
Shareholders' Funds108.48152.62207.66398.39464.75528.42
− Liabilities
Total Borrowings74.4593.9570.3613.780.206.45
Total Current Liabilities84.96101.6776.6739.4522.3125.69
Total Liabilities90.94107.5084.2643.4723.3228.19
− Assets
Fixed Assets22.4529.7636.2041.7140.0175.05
Investments8.638.492.9643.2751.20135.71
Cash & Equivalents5.158.064.86146.70105.3338.42
Total Current Assets175.57223.72256.34393.89444.04478.93
Total Assets209.94264.14297.79448.98497.93569.25
Financial Statements

Cash Flow

Annual · ₹ Cr
Cash from operationsNet cash flow ₹ crore
ParticularsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Cash Flows
Cash from Operations-7.356.7531.1675.96-11.2043.57
Cash from Investing-5.60-5.42-4.90-139.8524.76-59.66
Cash from Financing16.96-0.19-28.57107.03-28.880.92
Net Cash Flow4.011.15-2.3043.15-15.32-15.16
− Cash Position
Closing Cash4.715.853.5546.6931.3816.22

Shareholding Pattern

Promoters hold 71.0% of J.G.Chemicals, more than half. Since Mar 2024, foreign institutions’ share has fallen from 6.2% to 3.8%, while public shareholders’ share has risen from 19.6% to 23.1%.

J.G.Chemicals shareholding by quarter, per cent of shares, oldest first
HolderMar ’2411 Mar ’24Jun ’24Sep ’24Dec ’24Mar ’25Jun ’25Sep ’25Dec ’25Mar ’26Jun ’26Sep ’26
Promoters71.0%71.0%71.0%71.0%71.0%71.0%71.0%71.0%71.0%71.0%71.0%71.0%
Foreign institutions FII6.2%7.1%6.3%6.6%6.0%6.1%6.1%4.3%3.2%3.3%3.2%3.8%
Indian institutions DII3.2%5.4%3.6%3.8%3.9%3.7%3.5%3.2%3.5%3.5%3.0%2.1%
Public19.6%16.5%19.0%18.6%19.0%19.2%19.5%21.5%22.3%22.3%22.8%23.1%

Darker shading marks the quarters when that holder owned more.

Dividend History

J.G.Chemicals paid ₹1.10 per share in dividends in the last 12 months, in one payment. That is 0.19% of the share price, its dividend yield.

Per share, by year

  1. 2026so far ₹1.10per share one payment
  2. 2025 ₹1.00per share one payment

By calendar year of the ex-date. Records start Aug 2025.

Important Disclaimer

Not SEBI registered. No investment advice. StockRank.in is a software, data, and analytics platform operated by Teleport Creative. We are not registered with the Securities and Exchange Board of India (SEBI) in any capacity — we are not an investment adviser under the SEBI (Investment Advisers) Regulations, 2013, not a research analyst under the SEBI (Research Analysts) Regulations, 2014, and not a stockbroker, portfolio manager, or any other SEBI-regulated intermediary. Content is for general information and education, not personalised investment advice. These disclosures do not limit obligations imposed by applicable law.

No recommendations or solicitation. Valuation estimates, scores, rankings, screeners, charts and AI-generated research are not recommendations, offers or inducements to buy, sell, hold or subscribe to any security. A model estimate or a difference from market price is not a price target or promised return. Research shortlists are not recommended portfolios.

Model outputs are estimates, not facts. Estimates from the DCF valuation model depend on available financial information and assumptions. Frameworks may differ by business type. Models cannot capture every business risk and may rely on delayed or erroneous data. Results can be materially wrong and change as information or methods are updated. AI-generated research can omit context, misinterpret information or produce unsupported statements.

Data provided "as is". Market data displayed on StockRank.in is delayed and not real-time. Price data, financial statements, and derived metrics are sourced from third-party providers believed to be reliable but are provided "as is" and "as available", without warranty of any kind, express or implied — including accuracy, completeness, timeliness, merchantability, or fitness for a particular purpose. Always verify information independently against official sources such as exchange filings and annual reports before acting. Errors and omissions excepted.

Market risk & suitability. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Past performance and model outputs are not indicative of future results, and no returns are assured or guaranteed. Content on this website is generic and does not consider your investment objectives, financial situation, or risk tolerance. Use of this website does not create any adviser-client, fiduciary, or professional relationship. Please consult a SEBI-registered investment adviser before making any investment decision.

No liability. Beware of fraud. To the maximum extent permitted by law, Teleport Creative and StockRank.in shall not be liable for any losses or damages of any kind — direct, indirect, incidental, or consequential, including trading losses and lost profits — arising from the use of, or reliance on, this website. You are solely responsible for your investment decisions. StockRank does not send stock tips, does not operate Telegram or WhatsApp groups, never asks you to transfer funds for investment purposes, and never promises returns — anyone doing so in our name is an impersonator. Read the full Disclosures & Disclaimer